| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
3,870 |
3,016 |
$395K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
1,269 |
1,016 |
$199K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
471 |
415 |
$105K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,666 |
2,058 |
$99K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
2,156 |
1,728 |
$67K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
858 |
658 |
$55K |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
667 |
624 |
$45K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,282 |
824 |
$45K |
| G0483 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed |
1,099 |
671 |
$40K |
| G0482 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed |
565 |
444 |
$27K |
| 80053 |
Comprehensive metabolic panel |
2,484 |
1,882 |
$16K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
2,686 |
1,932 |
$13K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
177 |
90 |
$12K |
| 71046 |
Radiologic examination, chest; 2 views |
280 |
219 |
$8K |
| 36415 |
Collection of venous blood by venipuncture |
3,314 |
2,401 |
$6K |
| 87634 |
|
177 |
148 |
$6K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
156 |
125 |
$3K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
13 |
12 |
$3K |
| 87400 |
|
305 |
259 |
$3K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
220 |
160 |
$3K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
74 |
66 |
$3K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
356 |
254 |
$3K |
| 81001 |
|
1,449 |
1,120 |
$3K |
| 87430 |
|
205 |
171 |
$2K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
118 |
101 |
$2K |
| 85049 |
|
406 |
256 |
$838.41 |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
37 |
25 |
$628.71 |
| 71045 |
Radiologic examination, chest; single view |
21 |
16 |
$592.55 |
| 85041 |
|
405 |
257 |
$575.40 |
| 85048 |
|
409 |
258 |
$486.45 |
| 87551 |
|
24 |
12 |
$477.62 |
| 85014 |
|
405 |
258 |
$457.19 |
| 87481 |
|
38 |
25 |
$456.17 |
| 85018 |
|
415 |
269 |
$452.81 |
| 0011A |
|
48 |
36 |
$391.50 |
| 0012A |
|
22 |
18 |
$339.00 |
| 84443 |
Thyroid stimulating hormone (TSH) |
38 |
31 |
$166.53 |
| 82565 |
|
43 |
34 |
$119.86 |
| 82310 |
|
43 |
34 |
$116.00 |
| 84295 |
|
44 |
34 |
$112.58 |
| 87556 |
|
12 |
12 |
$112.53 |
| 84132 |
|
44 |
34 |
$111.28 |
| 82374 |
|
43 |
34 |
$109.75 |
| 84460 |
|
37 |
32 |
$109.71 |
| 84075 |
|
37 |
32 |
$107.18 |
| 84450 |
|
37 |
32 |
$107.18 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
15 |
13 |
$105.27 |
| 87541 |
|
12 |
12 |
$105.27 |
| 87581 |
|
13 |
12 |
$105.27 |
| 87486 |
|
13 |
12 |
$105.27 |
| 82435 |
|
41 |
34 |
$103.50 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,127 |
915 |
$97.61 |
| 82040 |
|
37 |
32 |
$93.58 |
| 0001A |
|
18 |
12 |
$93.00 |
| 84520 |
|
41 |
34 |
$89.00 |
| 81025 |
|
14 |
12 |
$81.00 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
63 |
39 |
$79.61 |
| 84155 |
|
37 |
32 |
$75.90 |
| 84484 |
|
26 |
13 |
$72.93 |
| 82247 |
|
23 |
19 |
$67.80 |
| 83690 |
|
16 |
12 |
$65.10 |
| 82947 |
|
25 |
20 |
$56.64 |
| 83992 |
|
51 |
41 |
$54.45 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
209 |
170 |
$14.44 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
235 |
212 |
$0.00 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
78 |
66 |
$0.00 |
| G0467 |
Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit |
206 |
157 |
$0.00 |
| 99335 |
|
352 |
335 |
$0.00 |
| 80359 |
|
48 |
41 |
$0.00 |
| 82962 |
|
170 |
160 |
$0.00 |
| 80353 |
|
48 |
41 |
$0.00 |
| 80358 |
|
48 |
41 |
$0.00 |
| 80324 |
|
48 |
41 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
83 |
66 |
$0.00 |
| 80357 |
|
19 |
14 |
$0.00 |
| 99336 |
|
31 |
30 |
$0.00 |
| 87631 |
|
203 |
164 |
$0.00 |
| 80361 |
|
48 |
41 |
$0.00 |
| 99173 |
|
13 |
13 |
$0.00 |
| 80323 |
|
48 |
41 |
$0.00 |
| 80348 |
|
48 |
41 |
$0.00 |
| 11720 |
|
29 |
29 |
$0.00 |
| 80365 |
|
48 |
41 |
$0.00 |
| 11721 |
|
13 |
13 |
$0.00 |
| 99334 |
|
900 |
652 |
$0.00 |
| 81002 |
|
13 |
13 |
$0.00 |
| 80354 |
|
48 |
41 |
$0.00 |
| 80356 |
|
48 |
41 |
$0.00 |
| 80369 |
|
25 |
23 |
$0.00 |
| 80373 |
|
48 |
41 |
$0.00 |
| 80372 |
|
47 |
40 |
$0.00 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
17 |
14 |
$0.00 |
| 80362 |
|
19 |
14 |
$0.00 |
| 80346 |
|
48 |
41 |
$0.00 |